Implementation of accelerated research: strategies for implementation as applied in a phase 1 Ad26.ZEBOV, MVA-BN-Filo two-dose Ebola vaccine clinical trial in Uganda

Implementation of accelerated research: strategies for implementation as applied in a phase 1 Ad26.ZEBOV, MVA-BN-Filo two-dose Ebola vaccine clinical trial in Uganda

Background The 2013–2016 Ebola epidemic in West Africa is the worst ever caused by Ebolaviruses with over 28,000 human cases and 11,325 deaths. The World Health Organisation (WHO) declared the epidemic a public health crisis that required accelerated development of novel interventions including vacc...

Full description

Bibliographic Details
Main Authors: Jonathan Kitonsa, Abu-Baker Ggayi, Zacchaeus Anywaine, Eva Kisaakye, Laura Nsangi, Vincent Basajja, Mary Nyantaro, Deborah Watson-Jones, Georgi Shukarev, Ine Ilsbroux, Cynthia Robinson, Pontiano Kaleebu
Format: Article
Language:English
Published: Taylor & Francis Group 2020-12-01
Series:Global Health Action
Subjects:
ebola virus disease
expedited approval
accelerated conduct
vaccine research
Online Access:http://dx.doi.org/10.1080/16549716.2020.1829829

Internet

http://dx.doi.org/10.1080/16549716.2020.1829829

Similar Items